Amyloidosis: Unraveling the Genetic Threads of a Complex Disease
Explore how genetic testing aids in diagnosing amyloidosis, understanding subtypes, guiding treatments, and providing crucial insights for personalized patient care.
Dr. Brandon Colby, MD
MD · MBA
Founder & CEO, Sequencing.com
Founder of Sequencing and author of Outsmart Your Genes. An early voice in direct-to-consumer genetic testing.
About
About Brandon
Brandon Colby is a physician-expert in the fields of Genetic Analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University`s Graduate School of Business, and a BA with Honors in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Education
Education
- MD, Mount Sinai School of Medicine
- MBA, Stanford University Graduate School of Business
- BS in Genetics, with Honors, University of Michigan
Affiliations & Memberships
Affiliations & Memberships
- Affiliate Specialist, American College of Medical Genetics and Genomics (ACMG)
- Associate, American College of Preventive Medicine (ACPM)
- Member, National Society of Genetic Counselors (NSGC)
Articles by Dr. Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Articles by Brandon
Androgen Resistance Syndrome: Understanding Genetic Testing's Role
Explore how genetic testing aids in diagnosing Androgen Resistance Syndrome, guiding treatment, offering psychosocial support, and enabling future family planning.
Anterior Segment Dysgenesis: Unlocking the Genetic Mysteries Through Testing
Unlocking genetic insights into anterior segment dysgenesis aids diagnosis, risk assessment, and innovative treatments, fostering better vision care in affected individuals.
Antisynthetase Syndrome: Unlocking the Genetic Code to Better Understand and Manage the Disease
Explore the role of genetic testing in diagnosing and managing Antisynthetase syndrome. Learn about genetic predisposition, targeted treatments, and genetic counseling.
Understanding ATTRV122I Amyloidosis: The Role of Genetic Testing in Diagnosis and Management
Explore ATTRV122I amyloidosis with insights on genetic testing for early diagnosis, family screening, and tailored treatments, enhancing patient management.
Advancements in Autosomal Dominant Intermediate Charcot-Marie-Tooth Disease: The Role of Genetic Testing
Explore how genetic testing uncovers genetic mutations in Autosomal Dominant Intermediate Charcot-Marie-Tooth Disease, aiding early diagnosis and personalized treatment.
Decoding the Silence: Understanding Autosomal Dominant Nonsyndromic Hearing Loss
Explore autosomal dominant nonsyndromic hearing loss, its genetic roots, and how advanced genetic testing, like identifying the CEACAM16 variant, aids diagnosis.
Understanding Autosomal Erythropoietic Protoporphyria: The Role of Genetic Testing in Diagnosis and Management
Explore the crucial role of genetic testing in diagnosing and managing autosomal erythropoietic protoporphyria, a rare disorder causing severe photosensitivity.